Two markers miss small percentage of high-grade prostate Ca Interview with Claire M. de la Calle, MD   The case for SBRT as renal cell carcinoma treatment Interview with Vitaly Margulis, MD Watch video interviews ADVERTISEMENT ADVERTISEMENT